Privia Health Group, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Privia Health Group, Inc. (PRVA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are PRVA insiders buying or selling?
In the last 12 months, Privia Health Group, Inc. insiders reported 0 open-market purchases ($0) and 24 sales ($22.2M) — net selling of $22.2M. Since May 2021, Trabud has recorded 208 Form 4 filings for PRVA: 5 buys ($9.3M) and 203 sells ($4.6B).
Source: SEC EDGAR Form 4
What stands out
- No Privia Health Group, Inc. insider made an open-market purchase in the last 12 months; the 24 reported open-market sales totaled $22.2M.
Key Statistics (May 2021 – Jul 13, 2026)
Total Form 4 filings
208
SEC EDGAR
Insider filers
14
Insider buys (5)
$9.3M
Insider sells (203)
$4.6B
Insider sentiment
Net sellingNet insider flow of $4.6B in net selling since May 2021, and $22.2M in net selling over the last 12 months.
Recent PRVA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 13, 2026 | David Mountcastle | EVP & Chief Financial Officer | Sale | 21.3K | $27.67 | $588.7K | SEC ↗ |
| Jul 9, 2026 | David Mountcastle | EVP & Chief Financial Officer | Sale | 600 | $27.57 | $16.5K | SEC ↗ |
| Jul 7, 2026 | Matthew Shawn Morris | Director | Sale | 112.8K | $27.29 | $3.1M | SEC ↗ |
| Jul 7, 2026 | David Mountcastle | EVP & Chief Financial Officer | Sale | 24.7K | $27.50 | $680.2K | SEC ↗ |
| Jul 2, 2026 | Matthew Shawn Morris | Director | Sale | 135.5K | $26.32 | $3.6M | SEC ↗ |
| Jun 30, 2026 | Matthew Shawn Morris | Director | Sale | 151.3K | $25.33 | $3.8M | SEC ↗ |
| Jun 30, 2026 | David Mountcastle | EVP & Chief Financial Officer | Sale | 17.2K | $25.18 | $433.0K | SEC ↗ |
| May 13, 2026 | Parth Mehrotra | Chief Executive Officer | Sale | 121.1K | $22.56 | $2.7M | SEC ↗ |
| May 13, 2026 | David Mountcastle | EVP & Chief Financial Officer | Sale | 3.4K | $22.60 | $76.5K | SEC ↗ |
| May 6, 2026 | David Mountcastle | EVP & Chief Financial Officer | Sale | 8.4K | $25.03 | $209.8K | SEC ↗ |
| May 5, 2026 | Matthew Shawn Morris | Director | Sale | 18.1K | $24.99 | $452.6K | SEC ↗ |
| Apr 6, 2026 | David Mountcastle | EVP & Chief Financial Officer | Sale | 5.6K | $20.85 | $116.1K | SEC ↗ |
| Mar 18, 2026 | David Mountcastle | EVP & Chief Financial Officer | Sale | 6.4K | $22.11 | $141.3K | SEC ↗ |
| Mar 18, 2026 | Parth Mehrotra | Chief Executive Officer | Sale | 26.5K | $22.11 | $586.1K | SEC ↗ |
| Mar 16, 2026 | David Mountcastle | EVP & Chief Financial Officer | Sale | 13.0K | $21.71 | $282.6K | SEC ↗ |
| Mar 16, 2026 | Parth Mehrotra | Chief Executive Officer | Sale | 54.0K | $21.71 | $1.2M | SEC ↗ |
| Mar 12, 2026 | Parth Mehrotra | Chief Executive Officer | Sale | 21.1K | $22.71 | $479.1K | SEC ↗ |
| Mar 10, 2026 | Parth Mehrotra | Chief Executive Officer | Sale | 63.4K | $22.95 | $1.5M | SEC ↗ |
| Mar 10, 2026 | Edward C Fargis | EVP & General Counsel | Sale | 9.3K | $22.99 | $214.8K | SEC ↗ |
| Mar 10, 2026 | David Mountcastle | EVP & Chief Financial Officer | Sale | 11.0K | $22.99 | $253.0K | SEC ↗ |
| Mar 2, 2026 | Matthew Shawn Morris | Director | Sale | 24.3K | $25.00 | $608.4K | SEC ↗ |
| Mar 2, 2026 | David Mountcastle | EVP & Chief Financial Officer | Sale | 13.1K | $25.03 | $326.8K | SEC ↗ |
| Dec 16, 2025 | Matthew Shawn Morris | Director | Sale | 13.6K | $25.01 | $341.3K | SEC ↗ |
| Dec 16, 2025 | David Mountcastle | EVP & Chief Financial Officer | Sale | 23.9K | $25.03 | $597.9K | SEC ↗ |
| May 14, 2025 | Parth Mehrotra | Chief Executive Officer | Sale | 29.7K | $24.74 | $734.3K | SEC ↗ |
Showing the 25 most recent of 208 Form 4 filings for Privia Health Group, Inc..
Most active PRVA insiders
- Parth Mehrotra49 filings
- Sullivan William M38 filings
- David Mountcastle34 filings
- Matthew Shawn Morris27 filings
- Thomas Bartrum25 filings
Ask anything about PRVA insider activity
Use Trabud's AI agent to query Privia Health Group, Inc.'s Form 4 history in plain English — "Show me PRVA CEO purchases this year" or compare it against any other ticker.
Open the AI agentPRVA insider trading FAQ
Are Privia Health Group, Inc. insiders buying or selling?
In the last 12 months, Privia Health Group, Inc. insiders reported 0 open-market purchases ($0) and 24 sales ($22.2M) — net selling of $22.2M. Since May 2021, Trabud has recorded 208 Form 4 filings for PRVA: 5 buys ($9.3M) and 203 sells ($4.6B). Over the full record that is net selling of $4.6B.
How many insiders trade PRVA stock?
14 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Privia Health Group, Inc.. The most recent filing was accepted on Jul 13, 2026.
Where does Trabud get PRVA insider trading data?
All PRVA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.